search
Back to results

Intravenous Paracetamol for Postoperative Pain (IVPARACET)

Primary Purpose

Pain, Postoperative, Recovery of Function, Child

Status
Completed
Phase
Phase 4
Locations
Lithuania
Study Type
Interventional
Intervention
Paracetamol
Placebo (for paracetamol)
Ketoprofen
Tramadol
Morphine
Sponsored by
Lithuanian University of Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative focused on measuring Pain, Postoperative, Paracetamol, Administration, Intravenous, Anti-Inflammatory Agents, Non-Steroidal, Child, Adolescent

Eligibility Criteria

1 Year - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 1-18 years of age, undergoing general, plastic or orthopedic surgery with expected median to severe pain postoperatively.
  • physical status of the patient corresponding to American Society of Anesthesiologists (ASA) class 1 or 2
  • Signed written informed consent by parents/official caregivers.

Exclusion Criteria:

  • Allergy to paracetamol, ketoprofen, tramadol, morphine or any NSAID
  • oncologic disease
  • central nervous system disease
  • renal dysfunction
  • hepatic dysfunction
  • bronchial asthma
  • ulcer(s) in gastrointestinal system
  • hemorrhagic diathesis
  • chronic use of NSAIDs
  • chronic use of opioids
  • chronic use of anticoagulants
  • female patient is known to be pregnant

Sites / Locations

  • Lithuanian University of Health Sciences Kaunas Clinics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

paracetamol and ketoprofen

placebo and ketoprofen

Arm Description

paracetamol 20 mg/kg (1% 2 ml/kg) IV at the end of surgery 6 and 20 hours thereafter. ketoprofen 1.5 mg/kg IV at the end of surgery 8 and 16 hours thereafter. tramadol 2 mg/kg IV on patient request up til 4 mg/kg or PCA morphine during 24 hours postoperatively.

0.9% sodium chloride (2 ml/kg) IV at the end of surgery 6 and 20 hours thereafter. ketoprofen 1.5 mg/kg IV at the end of surgery 8 and 16 hours thereafter. tramadol 2 mg/kg IV on patient request up til 4 mg/kg or PCA morphine during 24 hours postoperatively.

Outcomes

Primary Outcome Measures

change in postoperative intravenous opioid dose

Secondary Outcome Measures

change in pain level (analgesia) assessed by 10 point pain scales
change in pain level (analgesia) assessed by 10 point pain scales

Full Information

First Posted
September 22, 2014
Last Updated
March 3, 2017
Sponsor
Lithuanian University of Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT02248493
Brief Title
Intravenous Paracetamol for Postoperative Pain
Acronym
IVPARACET
Official Title
The Effect of Intravenous Paracetamol in Combination With NSAIDs for Postoperative Pain in Children
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
March 2017 (Actual)
Study Completion Date
March 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Lithuanian University of Health Sciences

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to define if intravenous paracetamol may improve analgesia and outcome in pediatric surgical patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) postoperatively. Hypothesis: intravenous paracetamol in a dose 60 mg/kg/24 h IV, given in addition to IV ketoprofen (4,5 mg/kg/24h), improves analgesia and physical recovery in children and adolescents following surgery.
Detailed Description
Patients aged 1-18 years undergoing general, plastic or orthopedic surgery with expected moderate to severe pain at least for 24 hours postoperatively, who meet inclusion criteria and does not meet exclusion criteria, are enrolled. At the end of surgical procedure, at skin closure, all patients are given 1,5 mg/kg intravenous ketoprofen and repeated every 8 hours up till 4,5 mg/kg/24 h. Patients in paracetamol group are additionally given the first dose of IV paracetamol 20 mg/kg and repeated 6 and 20 hours postoperatively up till 60 mg/kg/24 h. Patients in the placebo group are given 0.9% sodium chloride 2 ml/kg IV and repeated 6 and 20 hours postoperatively. After surgery optional rescue analgesia is given on patient request: either tramadol in a dose of 2 mg/kg (up till 4 mg/kg/24h), either patient-controlled analgesia (PCA) with morphine, as indicated according to the standard of care. Patients are evaluated up till 24 hours postoperatively. After that patients are followed up as long as indicated per standard of care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Recovery of Function, Child
Keywords
Pain, Postoperative, Paracetamol, Administration, Intravenous, Anti-Inflammatory Agents, Non-Steroidal, Child, Adolescent

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
54 (Actual)

8. Arms, Groups, and Interventions

Arm Title
paracetamol and ketoprofen
Arm Type
Experimental
Arm Description
paracetamol 20 mg/kg (1% 2 ml/kg) IV at the end of surgery 6 and 20 hours thereafter. ketoprofen 1.5 mg/kg IV at the end of surgery 8 and 16 hours thereafter. tramadol 2 mg/kg IV on patient request up til 4 mg/kg or PCA morphine during 24 hours postoperatively.
Arm Title
placebo and ketoprofen
Arm Type
Placebo Comparator
Arm Description
0.9% sodium chloride (2 ml/kg) IV at the end of surgery 6 and 20 hours thereafter. ketoprofen 1.5 mg/kg IV at the end of surgery 8 and 16 hours thereafter. tramadol 2 mg/kg IV on patient request up til 4 mg/kg or PCA morphine during 24 hours postoperatively.
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Other Intervention Name(s)
Acetaminophen
Intervention Type
Drug
Intervention Name(s)
Placebo (for paracetamol)
Other Intervention Name(s)
0.9% sodium cloride solution, Normal saline solution, Izotonic saline solution
Intervention Type
Drug
Intervention Name(s)
Ketoprofen
Other Intervention Name(s)
Ketonal
Intervention Type
Drug
Intervention Name(s)
Tramadol
Other Intervention Name(s)
Tramal
Intervention Description
Administered on request as rescue medication in a dose 2 mg/kg IV up till 2 doses. No other opioid is given to these patients.
Intervention Type
Drug
Intervention Name(s)
Morphine
Intervention Description
administered in patients receiving IV PCA with morphine postoperatively. No other opioid is given to these patients.
Primary Outcome Measure Information:
Title
change in postoperative intravenous opioid dose
Time Frame
24 hours postoperatively
Secondary Outcome Measure Information:
Title
change in pain level (analgesia) assessed by 10 point pain scales
Time Frame
1 hour postoperatively
Title
change in pain level (analgesia) assessed by 10 point pain scales
Time Frame
24 hours postoperatively
Other Pre-specified Outcome Measures:
Title
time until the first oral intake after surgery
Time Frame
24 hours postoperatively
Title
time until the first urination after surgery
Time Frame
24 hours postoperatively
Title
time until ambulation after surgery
Time Frame
24 hours postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients 1-18 years of age, undergoing general, plastic or orthopedic surgery with expected median to severe pain postoperatively. physical status of the patient corresponding to American Society of Anesthesiologists (ASA) class 1 or 2 Signed written informed consent by parents/official caregivers. Exclusion Criteria: Allergy to paracetamol, ketoprofen, tramadol, morphine or any NSAID oncologic disease central nervous system disease renal dysfunction hepatic dysfunction bronchial asthma ulcer(s) in gastrointestinal system hemorrhagic diathesis chronic use of NSAIDs chronic use of opioids chronic use of anticoagulants female patient is known to be pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Danguole C Rugyte, MD. PhD
Organizational Affiliation
Lithuanian University of Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lithuanian University of Health Sciences Kaunas Clinics
City
Kaunas
ZIP/Postal Code
50009
Country
Lithuania

12. IPD Sharing Statement

Citations:
PubMed Identifier
20142348
Citation
Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010 Apr 1;110(4):1170-9. doi: 10.1213/ANE.0b013e3181cf9281. Epub 2010 Feb 8.
Results Reference
background
PubMed Identifier
23570544
Citation
Wong I, St John-Green C, Walker SM. Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children. Paediatr Anaesth. 2013 Jun;23(6):475-95. doi: 10.1111/pan.12163. Epub 2013 Apr 9.
Results Reference
background
PubMed Identifier
15352967
Citation
Hiller A, Silvanto M, Savolainen S, Tarkkila P. Propacetamol and diclofenac alone and in combination for analgesia after elective tonsillectomy. Acta Anaesthesiol Scand. 2004 Oct;48(9):1185-9. doi: 10.1111/j.1399-6576.2004.00473.x.
Results Reference
background
PubMed Identifier
17185016
Citation
Rugyte D, Kokki H. Intravenous ketoprofen as an adjunct to patient-controlled analgesia morphine in adolescents with thoracic surgery: a placebo controlled double-blinded study. Eur J Pain. 2007 Aug;11(6):694-9. doi: 10.1016/j.ejpain.2006.11.001. Epub 2006 Dec 20.
Results Reference
background

Learn more about this trial

Intravenous Paracetamol for Postoperative Pain

We'll reach out to this number within 24 hrs